Literature DB >> 21664468

In vivo lysogenization of a Clostridium difficile bacteriophage ФCD119.

Govind Revathi1, Joe A Fralick, Rial D Rolfe.   

Abstract

Clostridium difficile is a nosocomial pathogen identified as the cause of antibiotic-associated diarrhea and colitis. In this study, we have documented the lysogeny of a C. difficile bacteriophage in hamsters during C. difficile infection. The lysogens isolated from the hamsters were toxin typed and their phage integration site was confirmed by PCR. Through toxin ELISA it was found that the toxin production in the in vivo isolated lysogens was affected due to ФCD119 lysogenization as in the case of in vitro isolated ФCD119 lysogens. Together our findings indicate that a baceriophage can lysogenize its C. difficile host even during the infection process and highlights the importance of lysogeny of C. difficile phages as an evolutionary adaptation for survival.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664468      PMCID: PMC3142996          DOI: 10.1016/j.anaerobe.2011.05.012

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  31 in total

1.  Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor.

Authors:  N Mani; B Dupuy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 2.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

3.  Effect of phage infection on toxin production by Clostridium difficile.

Authors:  Shan Goh; Barbara J Chang; Thomas V Riley
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

4.  [Pseudomembraneous colitis caused by a toxin B-positive and a toxin A-negative strain of Clostridium difficile].

Authors:  Lars Jakobsen; Michael Tvede
Journal:  Ugeskr Laeger       Date:  2006-04-24

5.  Two bacteriophages of Clostridium difficile.

Authors:  D E Mahony; P D Bell; K B Easterbrook
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

6.  Genomic organization and molecular characterization of Clostridium difficile bacteriophage PhiCD119.

Authors:  Revathi Govind; Joe A Fralick; Rial D Rolfe
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

Review 7.  Clostridium difficile toxin synthesis is negatively regulated by TcdC.

Authors:  B Dupuy; R Govind; A Antunes; S Matamouros
Journal:  J Med Microbiol       Date:  2008-06       Impact factor: 2.472

8.  A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.

Authors:  M Rupnik; V Avesani; M Janc; C von Eichel-Streiber; M Delmée
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

9.  Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.

Authors:  Susana Matamouros; Patrick England; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

10.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583

View more
  13 in total

Review 1.  Clostridioides difficile phage biology and application.

Authors:  Joshua Heuler; Louis-Charles Fortier; Xingmin Sun
Journal:  FEMS Microbiol Rev       Date:  2021-09-08       Impact factor: 16.408

2.  As Clear as Mud? Determining the Diversity and Prevalence of Prophages in the Draft Genomes of Estuarine Isolates of Clostridium difficile.

Authors:  Katherine R Hargreaves; James R Otieno; Anisha Thanki; Matthew J Blades; Andrew D Millard; Hilary P Browne; Trevor D Lawley; Martha R J Clokie
Journal:  Genome Biol Evol       Date:  2015-05-27       Impact factor: 3.416

3.  Phage ϕC2 mediates transduction of Tn6215, encoding erythromycin resistance, between Clostridium difficile strains.

Authors:  Shan Goh; Haitham Hussain; Barbara J Chang; Warren Emmett; Thomas V Riley; Peter Mullany
Journal:  mBio       Date:  2013-11-19       Impact factor: 7.867

4.  'Get in Early'; Biofilm and Wax Moth (Galleria mellonella) Models Reveal New Insights into the Therapeutic Potential of Clostridium difficile Bacteriophages.

Authors:  Janet Y Nale; Mahananda Chutia; Philippa Carr; Peter T Hickenbotham; Martha R J Clokie
Journal:  Front Microbiol       Date:  2016-08-31       Impact factor: 5.640

5.  Bacteriophages are more virulent to bacteria with human cells than they are in bacterial culture; insights from HT-29 cells.

Authors:  Jinyu Shan; Ananthi Ramachandran; Anisha M Thanki; Fatima B I Vukusic; Jakub Barylski; Martha R J Clokie
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

6.  Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model.

Authors:  Janet Y Nale; Tamsin A Redgwell; Andrew Millard; Martha R J Clokie
Journal:  Antibiotics (Basel)       Date:  2018-02-13

7.  Recent advances in the treatment of C. difficile using biotherapeutic agents.

Authors:  Vo Van Giau; Hyon Lee; Seong Soo A An; John Hulme
Journal:  Infect Drug Resist       Date:  2019-06-10       Impact factor: 4.003

Review 8.  Clostridium difficile phages: still difficult?

Authors:  Katherine R Hargreaves; Martha R J Clokie
Journal:  Front Microbiol       Date:  2014-04-28       Impact factor: 5.640

9.  Bacteriophage Combinations Significantly Reduce Clostridium difficile Growth In Vitro and Proliferation In Vivo.

Authors:  Janet Y Nale; Janice Spencer; Katherine R Hargreaves; Anthony M Buckley; Przemysław Trzepiński; Gillian R Douce; Martha R J Clokie
Journal:  Antimicrob Agents Chemother       Date:  2015-12-07       Impact factor: 5.191

10.  In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials.

Authors:  Kurt Selle; Joshua R Fletcher; Hannah Tuson; Daniel S Schmitt; Lana McMillan; Gowrinarayani S Vridhambal; Alissa J Rivera; Stephanie A Montgomery; Louis-Charles Fortier; Rodolphe Barrangou; Casey M Theriot; David G Ousterout
Journal:  mBio       Date:  2020-03-10       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.